Since the TERT promoter mutations were reported first by Liu et al. in thyroid cancer [12], subsequently, a large number of studies have reported the association between TERT promoter mutations and clinical behaviors (including pathological features and prognosis) in thyroid cancer, especially in DTC [14–23]. Here, TERT is linked to thyroid gland carcinoma.